Cuatro proyectos de GETECCU han sido aceptados para ser presentados como póster o presentación oral en el próximo Congreso de ECCO que tendrá lugar en Copenhague del 6 al 9 de marzo:
Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper digestive tract involvement (CROHNEX study).
E. Sainz, Y. Zabana, I. Miguel, A. Fernández-Clotet, MJ. Casanova, M. Martín, et al.
Efficacy and safety of tacrolimus in Ulcerative Colitis: A nationwide, multicentric study from GETECCU
I. Rodríguez-Lago, J. Castro-Poceiro, A. Fernández-Clotet, F. Mesonero, A. López-San Román, A. López-García, L. Márquez, et al.
Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry
María José Casanova, María Chaparro, Miguel Mínguez, Elena Ricart, Carlos Taxonera, Santiago García-López, et al.
Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry. (REINA)
Margalida Calafat, Míriam Mañosa, Elena Ricart, Pilar Nos, Eva Iglesias, Isabel Vera, et al.
